Jacobs Levy Equity Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,358
| Closed | -$679K | – | 1026 |
|
|
2023
Q3 | $679K | Buy |
4,358
+563
| +15% | +$92.9K | ﹤0.01% | 744 |
|
|
2023
Q2 | $628K | Sell |
3,795
-89
| -2% | -$14.4K | ﹤0.01% | 780 |
|
|
2023
Q1 | $602K | Sell |
3,884
-5,463
| -58% | -$882K | ﹤0.01% | 776 |
|
|
2022
Q4 | $1.65M | Sell |
9,347
-479
| -5% | -$82.7K | 0.01% | 597 |
|
|
2022
Q3 | $1.6M | Buy |
9,826
+1,000
| +11% | +$169K | 0.01% | 606 |
|
|
2022
Q2 | $1.57M | Buy |
8,826
+2,535
| +40% | +$452K | 0.01% | 659 |
|
|
2022
Q1 | $1.11M | Buy |
6,291
+1,957
| +45% | +$333K | 0.01% | 738 |
|
|
2021
Q4 | $741K | Sell |
4,334
-1,466
| -25% | -$240K | 0.01% | 786 |
|
|
2021
Q3 | $937K | Buy |
5,800
+619
| +12% | +$106K | 0.01% | 760 |
|
|
2021
Q2 | $854K | Buy |
5,181
+2,432
| +88% | +$403K | 0.01% | 770 |
|
|
2021
Q1 | $452K | Sell |
2,749
-1,295
| -32% | -$210K | ﹤0.01% | 872 |
|
|
2020
Q4 | $636K | Sell |
4,044
-6,351
| -61% | -$937K | 0.01% | 816 |
|
|
2020
Q3 | $1.55M | Buy |
10,395
+2,701
| +35% | +$400K | 0.02% | 566 |
|
|
2020
Q2 | $1.08M | Sell |
7,694
-4,834
| -39% | -$704K | 0.01% | 659 |
|
|
2020
Q1 | $1.64M | Buy |
12,528
+3,947
| +46% | +$560K | 0.02% | 527 |
|
|
2019
Q4 | $1.25M | Sell |
8,581
-5,369
| -38% | -$728K | 0.01% | 644 |
|
|
2019
Q3 | $1.8M | Sell |
13,950
-25,210
| -64% | -$3.32M | 0.02% | 533 |
|
|
2019
Q2 | $5.45M | Buy |
39,160
+18,180
| +87% | +$2.52M | 0.08% | 326 |
|
|
2019
Q1 | $2.93M | Buy |
20,980
+2,640
| +14% | +$354K | 0.04% | 434 |
|
|
2018
Q4 | $2.37M | Sell |
18,340
-12,850
| -41% | -$1.79M | 0.04% | 425 |
|
|
2018
Q3 | $4.31M | Sell |
31,190
-47,910
| -61% | -$6.37M | 0.06% | 346 |
|
|
2018
Q2 | $9.6M | Sell |
79,100
-5,030
| -6% | -$628K | 0.15% | 185 |
|
|
2018
Q1 | $10.8M | Buy |
84,130
+63,440
| +307% | +$8.57M | 0.18% | 169 |
|
|
2017
Q4 | $2.89M | Sell |
20,690
-261,840
| -93% | -$36.5M | 0.05% | 388 |
|
|
2017
Q3 | $36.7M | Sell |
282,530
-1,700
| -0.6% | -$225K | 0.71% | 11 |
|
|
2017
Q2 | $37.6M | Sell |
284,230
-77,930
| -22% | -$9.94M | 0.8% | 7 |
|
|
2017
Q1 | $45.1M | Sell |
362,160
-15,300
| -4% | -$1.83M | 0.91% | 6 |
|
|
2016
Q4 | $43.5M | Sell |
377,460
-103,000
| -21% | -$11.9M | 0.84% | 9 |
|
|
2016
Q3 | $56.8M | Buy |
480,460
+75,390
| +19% | +$9.15M | 1.01% | 6 |
|
|
2016
Q2 | $49.1M | Buy |
405,070
+78,240
| +24% | +$8.89M | 1.02% | 6 |
|
|
2016
Q1 | $35.4M | Buy |
326,830
+6,060
| +2% | +$627K | 0.75% | 16 |
|
|
2015
Q4 | $32.9M | Sell |
320,770
-65,810
| -17% | -$6.62M | 0.65% | 34 |
|
|
2015
Q3 | $36.1M | Sell |
386,580
-29,650
| -7% | -$2.87M | 0.74% | 26 |
|
|
2015
Q2 | $40.6M | Sell |
416,230
-362,220
| -47% | -$36.3M | 0.77% | 24 |
|
|
2015
Q1 | $78.3M | Sell |
778,450
-8,380
| -1% | -$852K | 1.33% | 2 |
|
|
2014
Q4 | $82.3M | Sell |
786,830
-60,900
| -7% | -$6.42M | 1.41% | 2 |
|
|
2014
Q3 | $90.4M | Hold |
847,730
| – | – | 1.51% | 2 |
|
|
2014
Q2 | $88.7M | Sell |
847,730
-20,440
| -2% | -$2.07M | 1.47% | 2 |
|
|
2014
Q1 | $85.3M | Sell |
868,170
-24,920
| -3% | -$2.31M | 1.43% | 2 |
|
|
2013
Q4 | $81.8M | Buy |
893,090
+31,380
| +4% | +$2.89M | 1.23% | 2 |
|
|
2013
Q3 | $74.7M | Buy |
861,710
+297,900
| +53% | +$26.7M | 1.27% | 3 |
|
|
2013
Q2 | $48.4M | Buy |
+563,810
| New | +$47.8M | 0.86% | 14 |
|
Other funds holding JNJ
Jacobs Levy Equity Management's JNJ Position: Q4 2023 in Review
Jacobs Levy Equity Management sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 4,358 shares — an estimated $679K sold.
Jacobs Levy Equity Management first reported a position in JNJ in Q2 2013 and held it in 42 quarters. The position peaked at $90.4M in Q3 2014. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.
- Jacobs Levy Equity Management reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
- Jacobs Levy Equity Management sold 4,358 Johnson & Johnson shares in Q4 2023, an estimated $679K.
- Jacobs Levy Equity Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 42 quarters.
- Jacobs Levy Equity Management's Johnson & Johnson position peaked at $90.4M in Q3 2014.
- 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.